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These are exciting and transitional times for the
International Society of Extracellular Vesicles (ISEV)
and its journal, the Journal of Extracellular Vesicles
(JEV). On 1 August 2019, the authors of this Editorial
have seen the end of seven years of hard but rewarding
work as Editors in Chief for the Journal, which they
have now handed over to Dr. Jan Lötvall, as the new
Editor in Chief of JEV.
In 2012, when a group of academic scientists lead by
Jan Lötvall decided to create the International Society
for Extracellular Vesicles (ISEV), the idea of creating
a journal for the society was immediately discussed.
Although some of us were not really supportive of
this idea, the most enthusiastic members of the ISEV
interim board convinced the others, and gathered the
required energy to find an experienced and reliable
publisher: the swedish company Co-Action. As
President of the interim ISEV board, Jan Lötvall acted
as interim Editor-in-Chief; he convinced renowned
extracellular vesicle (EV) scientists to submit articles
to the not-yet-born journal, with the first ongoing
volume of the Journal released on 15 April 2012 (in
time for the first ISEV annual meeting). After this
successful launch, the ISEV board created a three-
headed Editor-in-Chief board for the journal, with
one member of each major chapter of ISEV: Europe,
Americas and Asia-Pacific.
For us, it was the beginning of an exciting adven-
ture, in which we immediately benefited from the
strong support of the EV community. In particular,
the first call for editorial board members received
almost 70 applications, from which we selected 12
Associate Editors, and renewals and expansion of the
Associate Editorial board in 2015 and 2018 received the
same success. The former and current 21 Associate
Editors all showed strong involvement in their work
for the journal, not hesitating to ask for multiple
rounds of revisions to reach the high scientific and
experimental quality we wanted for the journal. In
addition, we acknowledge the amazing dedication of
the authors, who submitted their work even before the
journal was officially recognized by Scopus and
Thomson Reuters (in 2015), and of the reviewers for
their continued support in providing expertise to the
Journal. Thanks to all of the ISEV community, the
Journal has truly become a major communication
channel, publishing not only original research, techni-
cal and review articles, but also the abstracts of the
annual ISEV meeting, reports on various EV meetings,
editorials from the ISEV and JEV board, and letters to
the editors fostering discussion on EV topics.
During these years, we have endured an unexpected
change of publisher (when Co-action was sold to
Taylor and Francis at the end of 2016), but still
achieved recognition by Scopus in 2015 leading to
a CiteScore calculation in 2016 (our first CiteScore
was 13.15!). We have gone from partial recognition
by Thomson Reuters, who accepted JEV in its
“Emerging Sources Citation Index” in 2015 and started
tracking JEV articles for citations, to official recogni-
tion by Clarivate Analytics and inclusion of JEV in the
“Science Citation Index Expanded” in 2018. This lead
to the 2019 release of the first JEV impact factor (IF),
with a double-digit figure: 11.000. This is truly specta-
cular for a new journal, but we think well deserved.
This has been aided by the publications of the guideline
articles MISEV2014[1] and MISEV2018[2], establish-
ing standards for extracellular vesicle publication. In
addition, a multitude of “highly cited” papers contrib-
uted to the high IF of 2019 [3–7], but the journal also
published some “flagship” articles with very high cita-
tion scores in 2015 [8–10] and previous years [11–13],
which were not used for the 2019 IF calculation.
As expected, the initial volume of submissions coming
to the journal was low, and the acceptance rate relatively
high (even though acceptance sometimes required up to 3
revisions!), but submissions have steadily increased and
now with our newly announced impact factor has shown
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a major acceleration. This led to a major increase of
workload for the editors, and consequently, we have
already started increasing the stringency of acceptance,
and limiting the number of possible revisions. For the last
7 years, the requirements we had for articles published in
the journal were most importantly for high experimental
quality, with recognition of the specific issues and possi-
ble artefacts faced when working on EVs, and, of course,
absence of plagiarism, but we did not primarily require
novelty. We suspect that the new editorial team will face
an even bigger increase of submissions, and thus will
further increase the stringency of acceptance for publica-
tion in JEV. Keeping a good balance between technical
quality, scientific innovation, visibility, and the journal’s
quality of ISEV’s communication means, will be
a challenge for the new Editorial board, but we are sure
that innovative solutions will be found and appropriate
decisions will be made! We of course expect that the
Journal will keep showing the way for promoting open
and reproducible science in the EV field: by encouraging
submitting authors to read and understand the MISEV
guidelines and their updates[2], and to define clearly their
use of the nomenclature (EV versus exosomes: see this
recently published editorial[14]).
The prospects for continued successful evolution of
our journal are great and we are confident that under
the leadership of Dr. Lötvall there will continue to be
great advances for our journal. We wish him well on
his new venture.
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